GLAZER CAPITAL, LLC

Holdings History for Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (RVNC)

Symbol: RVNC
Investment type: Equity / Common Stock, par value $0.001 per share
Latest Disclosed Shares Owned: 0 shares
Security Ownership %: 0%

Shares, Excluding Options vs Price

Value, Excluding Options

Glazer Capital, LLC ownership in Revance Therapeutics, Inc. Common Stock, par value $0.001 per share (RVNC)

15 May 2025 - Glazer Capital, LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 0 shares of Revance Therapeutics, Inc. Common Stock, par value $0.001 per share (RVNC). This represents 0% ownership of the company. In their previous filing dated 06 Feb 2025, GLAZER CAPITAL, LLC had reported owning 7,210,121 shares, indicating a decrease of +100%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Glazer Capital, LLC	0%	-98%	$0	0	-7,210,121	-100%	$4.94	13G/A	31 Mar 2025	15 May 2025, 16:33
Glazer Capital, LLC	6.9%		$35,589,878	7,210,121			$4.94	13G	30 Jan 2025	06 Feb 2025, 18:19

Holdings date	Option	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Mar 2025			-0.4%	$0	0	-1,950,000	-100%	$3.65	Q1 2025
31 Dec 2024		0.4%	+0.4%	$5,928,000	1,950,000	+1,950,000	NEW	$3.04	Q4 2024
31 Dec 2024	call		0%	$35,000	2,725	0		$12.84 ^*	Q4 2024
30 Sep 2024	put		0%	$249,000	3,210	0		$77.57 ^*	Q3 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.